Patent application number | Description | Published |
20110257243 | 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS - In one aspect, the invention relates to compounds of formula I: | 10-20-2011 |
20120010265 | CRYSTALLINE FORM OF A 3-PHENOXYMETHYLPYRROLIDINE COMPOUND - The invention provides a crystalline hydrochloride salt of (S)-3-[(S)-1-(4-chlorophenoxy)-2-methylpropyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases. | 01-12-2012 |
20120088799 | SEROTONIN REUPTAKE INHIBITORS - In one aspect, the invention relates to compounds of formula I: | 04-12-2012 |
20120114600 | NOVEL INHIBITORS OF HEPATITIS C VIRUS - The invention provides compounds of formula (I): | 05-10-2012 |
20120142689 | SEROTONIN REUPTAKE INHIBITORS - In one aspect, the invention relates to compounds of formula I: | 06-07-2012 |
20120178790 | CRYSTALLINE FORM OF A 3-PHENOXYMETHYLPYRROLIDINE COMPOUND - The invention provides a crystalline hydrochloride salt of (S)-3-[(S)-1-(4-chlorophenoxy)-2-methylpropyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases. | 07-12-2012 |
20130178509 | 3-(PHENOXYPHENYLMETHYL)PYRROLIDINE COMPOUNDS - In one aspect, the invention relates to compounds of formula I: | 07-11-2013 |
20130237581 | 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS - In one aspect, the invention relates to compounds of formula I: | 09-12-2013 |
20130253013 | SEROTONIN REUPTAKE INHIBITORS - In one aspect, the invention relates to compounds of formula I: | 09-26-2013 |
20130296322 | SEROTONIN REUPTAKE INHIBITORS - In one aspect, the invention relates to compounds of formula I: | 11-07-2013 |
20140018407 | CRYSTALLINE FORM OF A 3-PHENOXYMETHYLPYRROLIDINE COMPOUND - The invention provides a crystalline hydrochloride salt of (S)-3-[(S)-1-(4-chlorophenoxy)-2-methylpropyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases. | 01-16-2014 |
20140243536 | SEROTONIN REUPTAKE INHIBITORS - In one aspect, the invention relates to compounds of formula I: | 08-28-2014 |
20150071878 | NOVEL INHIBITORS OF HEPATITIC C VIRUS - The invention provides compounds of formula (I): | 03-12-2015 |
20150080450 | CRYSTALLINE FORM OF A 3-PHENOXYMETHYLPYRROLIDINE COMPOUND - The invention provides a crystalline hydrochloride salt of (S)-3-[(S)-1-(4-chlorophenoxy)-2-methylpropyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases. | 03-19-2015 |